Membranoproliferative Glomerulonephritis
- 31 May 1984
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 310 (22), 1421-1426
- https://doi.org/10.1056/nejm198405313102203
Abstract
Forty patients with Type I membranoproliferative glomerulonephritis were treated for one year with dipyridamole, 225 mg per day, and aspirin, 975 mg per day, in a prospective, randomized, double-blind, placebo-controlled study. At the base line, the half-life of 51Cr-labeled platelets was reduced in 12 of 17 patients. The platelet half-life became longer and renal function stabilized in the treated group, as compared with the placebo group, suggesting a relation between platelet consumption and the glomerulopathy. The glomerular filtration rate, determined by iothalamate clearance, was better maintained in the treated group (average decrease, 1.3 ml per minute per 1.73 m2 of body-surface area per 12 months) than in the placebo group (average decrease, 19.6). Fewer patients in the treated group than in the placebo group had progression to end-stage renal disease (3 of 21 after 62 months as compared with 9 of 19 after 33 months). The data suggest that dipyridamole and aspirin slowed the deterioration of renal function and the development of end-stage renal disease. (N Engl J Med 1984; 310:1421–6.)This publication has 25 references indexed in Scilit:
- Differential Inhibition by Aspirin of Vascular and Platelet Prostaglandin Synthesis in Atherosclerotic PatientsNew England Journal of Medicine, 1983
- A Platelet-Inhibitor-Drug Trial in Coronary-Artery Bypass OperationsNew England Journal of Medicine, 1982
- Chemotaxis of monocytes and neutrophils to platelet-derived growth factor.JCI Insight, 1982
- Platelet survival and the development of coronary artery disease in the young adult: effects of cigarette smoking, strong family history and medical therapy.Circulation, 1981
- DIFFERENTIAL INHIBITION OF PROSTACYCLIN PRODUCTION AND PLATELET AGGREGATION BY ASPIRINThe Lancet, 1979
- Platelet suppressant therapy in patients with prosthetic cardiac valves. Relationship of clinical effectiveness to alteration of platelet survival time.Cell Metabolism, 1979
- Chronic progressive renal disease: Rate of change of serum creatinine concentrationKidney International, 1977
- Homocystine-induced arteriosclerosis. The role of endothelial cell injury and platelet response in its genesis.JCI Insight, 1976
- Mesangiocapillary glomerulonephritis: Changes in glomerular morphology with long-term alternate-day prednisone therapyThe Journal of Pediatrics, 1975
- Hypocomplementemic and normocomplementemic persistent (chronic) glomerulonephritis; clinical and pathologic characteristicsThe Journal of Pediatrics, 1965